Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind dose-finding study of KHK7580 vs cinacalcet in hemodialysis patients with secondary hyperparathyroidism
jRCT2080222580Phase 2
- Sponsor
- Kyowa Kirin
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ASP7991 in secondary hyperparathyroidism (SHPT) and chronic kidney disease (CKD) (2 arms), sponsored by Kyowa Kirin.
02
Drugs
ASP7991
03
Conditions
secondary hyperparathyroidism (SHPT)chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCT2080222580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222580.